# Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia

> **NCT01696383** · PHASE4 · WITHDRAWN · sponsor: **Alcon Research**

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost 0.004%/Timolol 0.5% Fixed Combination (DuoTrav)

## Key facts

- **NCT ID:** NCT01696383
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Management decision
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01696383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01696383, "Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01696383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*